Skip to content

Search for:

Home
About Us
Non-Viral
Products
- Instruments
  ATx™
  GTx™
  STx™
  VLx™
- Consumables
  RUO Processing Assemblies
  Processing Assemblies Accessories
  GMP Processing Assemblies
  Processing Assemblies Order / Quote Request
Resources
- Applications
  Cell-Based Assays
  Gene Editing
  Primary Cells
  Protein Production
  Stem Cells
  TCR/CAR T
- Publications
  Application Notes
  Posters
  Primary Literature
  Product Literature
  Webinars
  White Papers
  Scientific Brief
  Scientific Presentation
Investors
Events
- News
  MaxCyte® Minutes
  Twitter feed
  Virtual 3D booth
  News Releases
- Events
  Upcoming Events
  Webinars Series
  On Demand Live Seminars
  Investor Events
Contact Us

Search for:

MC-AP-CR5ali2019-04-29T04:37:32+00:00

Advancing a CCR5 Gene Editing Therapy to Clinical Trial: Overcoming Viral Vector Toxicity

Complete the form below to download the App Note.

ATX

GTX

STX

MaxCyte, Inc.

9713 Key West Avenue
Suite 400
Rockville, MD 20850
Tel: +1-301-944-1700

Life Sciences

Consumables

Careers

Legal

Applications

Investors

ExPERT Platform

MaxCyte Minutes

Instruments

About Us

Resources

Distributors

Web Analytics Made Easy -
StatCounter

free hit counter

© 2022 MaxCyte, Inc. All rights reserved. MaxCyte^®, MaxCyte ATx^®, MaxCyte GTx^®, MaxCyte STx^®, MaxCyte VLX^®, Flow Transfection^®, Flow Electroporation^®, Any Cell. Any Molecule. Any Scale.^®, CARMA^®, ^®, ^®, ^® and ^® are trademarks of MaxCyte, Inc., registered in the U.S. Patent and Trademark Office. MaxCyte GTx^TM, MaxCyte STx^TM, ExPERT ATx^TM, ExPERT GTx^TM, ExPERT STx^TM, ExPERT VLx^TM, ExPERT^TM, ATx^TM, GTx^TM, STx^TM, VLx^TM, ^TM, ^TM, MaxCyte CARMA^TM and CARMA Cell Therapies^TM are trademarks of MaxCyte, Inc.

Web Analytics Made Easy -
StatCounter